Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine
admin 26th March 2020 Uncategorised 0The vaccine met all primary endpoints in adults aged 65 and older against Sanofi’s Fluzone Quadrivalent.
More: Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine
Source: News